Evaluation of the north star ambulatory assessment scale and cardiac abnormalities in ambulant boys with duchenne muscular dystrophy

Journal of Paediatrics and Child Health

Volumn 48, Issue 7, 2012, Pages 610-616

  Ergul, Yakup ^a   Ekici, Baris ^a   Nisli, Kemal ^a   Tatli, Burak ^a   Binboga, Fatih ^a   Acar, Gonul ^a   Ozmen, Meral ^a   Omeroglu, Rukiye Eker ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

children; Duchenne muscular dystrophy; North Star

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; CREATINE KINASE MB; TROPONIN T;

AMBULATORY CARE; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DOPPLER ECHOCARDIOGRAPHY; DUCHENNE MUSCULAR DYSTROPHY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; NORTH STAR AMBULATORY ASSESSMENT SCALE; PATIENT ASSESSMENT; PR INTERVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; Q WAVE; QT PROLONGATION; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; ST SEGMENT DEPRESSION; T WAVE INVERSION;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CHILD; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TROPONIN T;

EID: 84863489790     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2012.02428.x     Document Type: Article

References (28)

1. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K,. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord. 2002; 12: 926-9. (Pubitemid 35408673)
2. Finsterer J, Stöllberger C,. The heart in human dystrophinopathies. Cardiology 2003; 99: 1-19. (Pubitemid 36206630)
3. Thrush PT, Allen HD, Viollet L, Mendell JR,. Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy. Am. J. Cardiol. 2009; 103: 262-5.
4. Connuck DM, Sleeper LA, Colan SD, et al,. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. Am. Heart J. 2008; 155: 998-1005.
5. Bushby K, Muntoni F, Bourke JP,. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7-9 June 2002, Naarden, the Netherlands. Neuromuscul. Disord. 2003; 13: 166-72. (Pubitemid 36140013)
6. Matsumura T, Saito T, Fujimura H, Shinno S,. Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients. Brain Dev. 2007; 29: 496-501. (Pubitemid 47223612)
7. Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S,. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr. Cardiol. 2005; 26: 66-72. (Pubitemid 41569564)
8. Allen HD, Mendell JR, Hoffman TM,. The heart in muscular dystrophies. In:, Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adam's Heart Disease in Infants, Children and Adolescent, 7th edn. Philedelphia: Lippincott Williams &Wilkins, 2008; 1234-42.
9. Manzur AY, Kinali M, Muntoni F,. Update on the management of Duchenne muscular dystrophy. Arch. Dis. Child. 2008; 93: 986-90.
10. Scott E, Eagle M, Main M,. The North Star Ambulatory Assessment. Abstract 31st annual meeting of the British Paediatric Neurology Association. 18-20 January 2006. Dev. Med. Child Neurol. 2006; 27.
11. Mazzone ES, Messina S, Vasco G, et al,. Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul. Disord. 2009; 19: 458-61.
12. Mazzone E, Martinelli D, Berardinelli A, et al,. North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy. Neuromuscul. Disord. 2010 Jul 13; 20: 712-16. [Epub ahead of print].
13. Davignon A, Rautaharju P, Boisselle E,. Normal ECG standards for infants and children. Pediatr. Cardiol. 1979; 1: 123-52.
14. Van Hare GF, Dubin AM,. The normal electrocardiogram. In:, Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adam's Heart Disease in Infants, Children and Adolescent, 7th edn. Philedelphia: Lippincott Williams &Wilkins, 2008; 253-68.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A,. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83. (Pubitemid 9091990)
16. Schiller NB, Shah PM, Crawford M, et al,. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J. Am. Soc. Echocardiogr. 1989; 2: 358-67.
17. Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH,. Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr. Cardiol. 2005; 26: 768-71. (Pubitemid 43130167)
18. Markham LW, Kinnett K, Wong BL, Woodrow Benson D, Cripe LH,. Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul. Disord. 2008; 18: 365-70.
19. Daftary AS, Crisanti M, Kalra M, Wong B, Amin R,. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics 2007; 119: 320-4.
20. Cox GF, Kunkel LM,. Dystrophies and heart disease. Curr. Opin. Cardiol. 1997; 12: 329-43. (Pubitemid 27252541)
21. Ogata H, Ishikawa Y, Ishikawa Y, Minami R,. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J. Cardiol. 2009; 53: 72-8.
22. Nigro G, Comi LI, Politano L, Bain RJ,. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 1990; 26: 271-7. (Pubitemid 20061348)
23. Takami Y, Takeshima Y, Awano H, Okizuka Y, Yagi M, Matsuo M,. High incidence of electrocardiogram abnormalities in young patients with Duchenne muscular dystrophy. Pediatr. Neurol. 2008; 39: 399-403.
24. Perloff JK, Roberts WC, de Leon AC Jr,. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic- pathologic correlative study. Am. J. Med. 1967; 42: 179-88.
25. Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K,. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr. Cardiol. 2002; 23: 160-6. (Pubitemid 36927893)
26. Kawai H, Adachi K, Kimura C, et al,. Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy. Arch. Neurol. 1990; 47: 900-4. (Pubitemid 20251722)
27. Lerman A, Gibbons RJ, Rodeheffer RJ, et al,. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105-9. (Pubitemid 23125852)
28. Manzur AY, Muntoni F,. Diagnosis and new treatments in muscular dystrophies. J. Neurol. Neurosurg. Psychiatry 2009; 80: 706-14.